NOVEL MCH RECEPTOR ANTAGONISTS

The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and relat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ALBERT KUDZOVI AMEGADZIE, STEVEN JAMES GREEN, YEN DAO, PATRICK GIANPIETRO SPINAZZE, JIANLIANG LU, ERIK JAMES HEMBRE, KEVIN MATTHEW GARDINIER, DAVID JOSEPH GARMENE
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases. La presente invención se refiere a un compuesto antagonista de la hormona concentradora de melanina de fórmula (I): en donde R1, Ra, Rb, R2, L1, R3, R4 y R5 son como se definen, o una sal, enantiómero, diastereómero, o mezcla de diastereómeros de los mismos, farmacéuticamente aceptables, útiles en el tratamiento de obesidad y enfermedades relacionadas. (ver fórmula (I)).